weight loss drugs not glp 1 Rx Trends: Real-World Data on GLP-1s for GLP-1s for Weight Loss: What

however, indications such as nonalcoholic steatohepatitis, Parkinsons disease, and Alzheimers disease are being explored

In lower-income states like Mississippi, Louisiana, and West Virginia, not so much but it depends on the price tag people are willing to put on feeling or looking healthier

doi: 10.1210/jc.2010-2822

Addressing barriers such as cost, long-term adherence, and patient selection criteria will be essential to optimize their integration into clinical practice

( 10.1056/NEJMoa1603827) [DOI] [PMC free article] [PubMed] [Google Scholar] McIntyre N Holdsworth CD & Turner DS

In a smaller subpopulation with clinical data available, MBS was found to be associated with significantly greater body weight reduction, as well as reductions in obesity-related comorbidities, than GLP-1 RAs over the follow-up period of 2 years